Not Tagged
Not Tagged
['biomarker']
there are still many unknowns.
we need to be objective in assessing the biology (the cellular part, not just molecular) in assessing utility of ctdna.
i'm a fan of using it as *a* correlative exploratory biomarker in prospective therapeutic trials that make sense. #asco23 
Physician-Scientist/Clinical Cancer Biologist. Clinical focus: GI Cancers/Neuro-Oncology. In lab: #TunnelingNanotubes and other drivers of La ChemoResistance